Peruvoside

Peruvoside
	File:Peruvoside.png
Systematic (IUPAC) name
	(3β,5β,8ξ,9ξ)- 3-[(6-deoxy- 3-O-methyl- α-D- glycero- hexopyranosyl)oxy]- 14-hydroxy- 19-oxocard- 20(22)enolide
Identifiers
CAS Number	1182-87-2
ATC code	C01AX02 (WHO)
PubChem	CID 14449
Synonyms	(3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde
Chemical data
Formula	C30H44O9
Molar mass	548.665 g/mol[[Script error: No such module "String".]]

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Peruvoside (or cannogenin thevetoside) is a cardiac glycoside^[1] for heart failure.^[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

30px	This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. v d e

↑ Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia nereifolia; Chemical, Pharmacological, and Clinical Studies. Arora, R. B.; Rangaswami, S. (1972), Publisher: (Thomson, New Delhi, India)
↑ ^2.0 ^2.1 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.